Skip to main content
Skip to section navigation
Skip to footer
About Us
Company Overview
Management
Board of Directors
Pipeline
Pipeline Overview
Paxalisib
PD-L1 Protein Degrader
SETDB1 Inhibitor
EVT801
Clinical Trials
Posters & Publications
Technology
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Investors
Investors Overview
News & Events
Company Info
Financial Results
Stock Data
SEC Filings
Governance
ASX Delisting
Contact Us
ASX Announcements
Media Center
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Jan 17, 2023
Application for quotation of securities - KZA
Jan 17, 2023
Application for quotation of securities - KZA
Jan 17, 2023
Cleansing notice
Jan 17, 2023
Cleansing notice
Jan 16, 2023
Kazia raises $4.5m and launches share purchase plan
Jan 16, 2023
Proposed issue of securities - KZA
Jan 12, 2023
Trading Halt
Dec 15, 2022
Kazia pre-clinical collaboration with QIMR
Dec 13, 2022
Kazia receives Nasdaq minimum bid notice
Dec 1, 2022
EVT801 preclinical data published
rss_feed
RSS
Previous Page
arrow_back
Page
1
…
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
…
Page
19
Next Page
arrow_forward
Select a page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
